Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UNIVERSAL BIOSENSORS INC. Investor Presentation 2024

Aug 6, 2024

65977_rns_2024-08-06_571f1388-27b4-41cc-a2cd-b22e9e9472cb.pdf

Investor Presentation

Open in viewer

Opens in your device viewer

ASX Announcement

7 August 2024

==> picture [103 x 41] intentionally omitted <==

Universal Biosensors to host investor briefing and Q&A

Universal Biosensors, Inc. (ASX: UBI) is pleased to announce it will host an investor briefing and Q&A session following the release of the Company’s FY24 Half Year Results.

The webinar will be held at 10:00am AEST on Friday 9[th] of August, where CEO John Sharman will present the slide deck lodged as part of the FY24 Half Year Results and discuss the latest developments in the business.

Shareholders, investors and interested parties are encouraged to register to attend the presentation at - - - - the following link: https://events.teams.microsoft.com/event/21df7eca 0a41 4c24 934e 1290b2f5609e@44b9b225-ea80-44ff-9206-5498af60931f

After registering, you will receive a confirmation email containing information about joining the webinar.

Questions can be posted in the Q&A function of the webinar during the briefing and will be answered after the initial presentation.

End

Announcement authorised by the Board of Directors of Universal Biosensors, Inc.

For further information contact:

Salesh Balak Company Secretary +61 (0) 414 508 852

1

Email [email protected] www.universalbiosensors.com

Telephone +61 3 9213 9000 Facsimile +61 3 9213 9099

Universal Biosensors, Inc. ARBN 121 559 993

1 Corporate Avenue, Rowville Victoria 3178, Australia

==> picture [92 x 38] intentionally omitted <==

About Universal Biosensors

Universal Biosensors, founded in 2001, specialises in the design and development of electrochemical cells (strips) used in conjunction with point of use devices that are used in various industries such as healthcare (point of care), wine, food, and agriculture. UBI’s ambition is to build a multi product stable of biosensors in large markets which generate ongoing revenue streams. For additional information regarding Universal Biosensors, Inc., refer to: http://www.universalbiosensors.com.

Forward-Looking Statements

The statements contained in this release that are not purely historical are forward-looking statements within the meaning of the US Securities Exchange Act of 1934. Forward-looking statements in this release include statements regarding our expectations, beliefs, hopes, intentions or strategies. All forward-looking statements included in this release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. Our actual results could differ materially from our current expectations. We cannot assure you when, if at all, the proposals outlined in this release will occur, and the terms of any such proposal are subject to change. Factors that could cause or contribute to such differences include, but are not limited to, factors and risks disclosed from time to time in reports filed with the SEC.

2